Glaucoma-related innovations available to license through Purdue OTC

January 11, 2022

Glaucoma-related innovations available to license through Purdue OTC

January is Glaucoma Awareness Month. Did you know glaucoma is the second-leading cause of blindness around the world? This group of diseases causes damage to the optic nerve in the eye. About three million Americans are affected by glaucoma according to the Centers for Disease Control and Prevention. There is no cure, but vision loss could be prevented if it is caught early.

Today we are sharing three innovations related to glaucoma discovered by Purdue University researchers. They have disclosed these innovations to the Purdue Research Foundation Office of Technology Commercialization (OTC).